Pfizer Files 8K - Changes Executive Management

Pfizer Inc. ( PFE ) filed a Form 8K - Changes in Company Executive Management - with the U.S Securities and Exchange Commission on June 26, 2014.

On June 26, 2014, the Company's Board of Directors expanded the size of the Board from 12 to 13 members and elected James C. Smith to serve as a member of the Board, effective immediately. In addition, he was appointed to the Corporate Governance Committee and the Science and Technology Committee of the Board.

Mr. Smith has been provided an indemnification agreement and will receive compensation in accordance with the Company's standard arrangements for non-employee directors. The press release dated June 26, 2014 announcing the election of Mr. Smith is attached hereto as Exhibit 99. The information contained in the press release is deemed to be filed under the Securities Exchange Act of 1934, and such press release is incorporated herein by reference.

The full text of this SEC filing can be retrieved at: n8k626.htm

Any exhibits and associated documents for this SEC filing can be retrieved at: 78003/000007800314000032/0000078003-14-000032-index.htm

Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the value of its shares.

Access Investor Kit for Pfizer Inc.


Subscribe to WSJ:

  (END) Dow Jones Newswires
  Copyright (c) 2014 Dow Jones & Company, Inc.